Rebin Kader
Overview
Explore the profile of Rebin Kader including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franco Melendez K, Crenshaw K, Barrila J, Yang J, Gangaraju S, Davis R, et al.
mSphere
. 2022 Aug;
7(4):e0021022.
PMID: 35913142
The discovery that biomechanical forces regulate microbial virulence was established with the finding that physiological low fluid shear (LFS) forces altered gene expression, stress responses, and virulence of the enteric...
2.
Kader R, Kennedy K, Portnoy J
Curr Allergy Asthma Rep
. 2018 Feb;
18(3):17.
PMID: 29470668
Purpose Of Review: The use of environmental interventions to improve outcomes in asthmatics has long been an elusive goal. While numerous interventions have been studied, the results of clinical trials...
3.
Juarez-Rodriguez M, Arteaga-Cortes L, Kader R, Curtiss 3rd R, Clark-Curtiss J
Infect Immun
. 2011 Dec;
80(2):798-814.
PMID: 22144486
Tuberculosis remains a global health threat, and there is dire need to develop a vaccine that is safe and efficacious and confers long-lasting protection. In this study, we constructed recombinant...
4.
Juarez-Rodriguez M, Yang J, Kader R, Alamuri P, Curtiss 3rd R, Clark-Curtiss J
Infect Immun
. 2011 Dec;
80(2):815-31.
PMID: 22144485
Live recombinant attenuated Salmonella vaccine (RASV) strains have great potential to induce protective immunity against Mycobacterium tuberculosis by delivering M. tuberculosis antigens. Recently, we reported that, in orally immunized mice,...
5.
Dieye Y, Dyszel J, Kader R, Ahmer B
BMC Microbiol
. 2007 Jan;
7:3.
PMID: 17233907
Background: The type III secretion system (TTSS) is an important virulence determinant of Gram-negative bacterial pathogens. It enables the injection of effector proteins into the cytosol of eukaryotic cells. These...